Stryker acquires Inari Medical for $4.9B, entering peripheral vascular intervention

Stryker's $4.9B acquisition of Inari Medical in 2025 establishes a major position in peripheral vascular intervention, signaling device-industry expansion into interventional radiology's core domain.

• The deal marks one of the largest moves by a major orthopedic/medtech company into peripheral vascular devices, which radiologists use for procedures like deep vein thrombosis and pulmonary embolism treatment.
• Stryker also later acquired Amplitude Vascular Systems (2026), further consolidating its vascular portfolio.
• This follows a decades-long strategy of targeted acquisitions rather than megamergers, with Stryker now among the most valued medical device companies.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.